(en) Suzanne Wood, Jennifer R. Sage, Tristan Shuman et Stephan G. Anagnostaras, « Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation », Pharmacological Reviews, vol. 66, no 1, , p. 193–221 (ISSN0031-6997, PMID24344115, PMCID3880463, DOI10.1124/pr.112.007054, lire en ligne, consulté le )
Guillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel et Alexandra Macgregor, « Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review », Psychiatry Research, vol. 229, no 1, , p. 12–20 (ISSN0165-1781, DOI10.1016/j.psychres.2015.07.006, lire en ligne, consulté le )
J. Micheau, T. P. Durkin, C. Destrade et Y. Rolland, « Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation », Pharmacology, Biochemistry, and Behavior, vol. 23, no 2, , p. 195–198 (ISSN0091-3057, PMID4059305, DOI10.1016/0091-3057(85)90555-6, lire en ligne, consulté le )
Gillies D, Sinn JKh, Lad SS, Leach MJ et Ross MJ, « Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents », Cochrane Database Syst Rev, vol. 7, no 7, , p. CD007986 (PMID22786509, DOI10.1002/14651858.CD007986.pub2)
Tan ML, Ho JJ, Teh KH, « Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders », Cochrane Database Syst Rev, vol. 12, , p. CD009398 (PMID23235675, DOI10.1002/14651858.CD009398.pub2)
Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P, « Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis », J. Psychopharmacol. (Oxford), vol. 29, no 7, , p. 753–63 (PMID26040902, DOI10.1177/0269881115587958)
Forbes SC, Holroyd-Leduc JM, Poulin MJ, Hogan DB, « Effect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled Trials », Can Geriatr J, vol. 18, no 4, , p. 231–45 (PMID26740832, PMCID4696451, DOI10.5770/cgj.18.189)
(en) Guillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel, Alexandra Macgregor, Stéphanie Miot, Régis Lopez, Raphaëlle Richieri, Mocrane Abbar, Christophe Lancon et Dimitris Repantis, « Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review », Psychiatry Research, vol. 229, nos 1–2, , p. 12–20 (ISSN0165-1781, PMID26187342, DOI10.1016/j.psychres.2015.07.006)
(en) Henry Greely, Barbara Sahakian, John Harris et Ronald C. Kessler, « Towards responsible use of cognitive-enhancing drugs by the healthy », Nature, vol. 456, no 7223, , p. 702–705 (ISSN0028-0836, DOI10.1038/456702a, lire en ligne, consulté le )
« Pour ou contre l’utilisation des « smart drugs » ? », Hinnovic, (lire en ligne, consulté le ).
issn.org
portal.issn.org
U. Senin, G. Abate, C. Fieschi et G. Gori, « Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study », European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, vol. 1, , p. 511–517 (ISSN0924-977X, PMID1822317, lire en ligne, consulté le )
(en) Suzanne Wood, Jennifer R. Sage, Tristan Shuman et Stephan G. Anagnostaras, « Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation », Pharmacological Reviews, vol. 66, no 1, , p. 193–221 (ISSN0031-6997, PMID24344115, PMCID3880463, DOI10.1124/pr.112.007054, lire en ligne, consulté le )
Guillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel et Alexandra Macgregor, « Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review », Psychiatry Research, vol. 229, no 1, , p. 12–20 (ISSN0165-1781, DOI10.1016/j.psychres.2015.07.006, lire en ligne, consulté le )
Kara Simone Bagot et Yifrah Kaminer, « Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review », Addiction (Abingdon, England), vol. 109, no 4, , p. 547–557 (ISSN0965-2140, PMID24749160, PMCID4471173, lire en ligne, consulté le )
J. Micheau, T. P. Durkin, C. Destrade et Y. Rolland, « Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation », Pharmacology, Biochemistry, and Behavior, vol. 23, no 2, , p. 195–198 (ISSN0091-3057, PMID4059305, DOI10.1016/0091-3057(85)90555-6, lire en ligne, consulté le )
(en) Guillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel, Alexandra Macgregor, Stéphanie Miot, Régis Lopez, Raphaëlle Richieri, Mocrane Abbar, Christophe Lancon et Dimitris Repantis, « Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review », Psychiatry Research, vol. 229, nos 1–2, , p. 12–20 (ISSN0165-1781, PMID26187342, DOI10.1016/j.psychres.2015.07.006)
(en) Henry Greely, Barbara Sahakian, John Harris et Ronald C. Kessler, « Towards responsible use of cognitive-enhancing drugs by the healthy », Nature, vol. 456, no 7223, , p. 702–705 (ISSN0028-0836, DOI10.1038/456702a, lire en ligne, consulté le )
(en) Henry Greely, Barbara Sahakian, John Harris et Ronald C. Kessler, « Towards responsible use of cognitive-enhancing drugs by the healthy », Nature, vol. 456, no 7223, , p. 702–705 (ISSN0028-0836, DOI10.1038/456702a, lire en ligne, consulté le )
nih.gov
ncbi.nlm.nih.gov
U. Senin, G. Abate, C. Fieschi et G. Gori, « Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study », European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, vol. 1, , p. 511–517 (ISSN0924-977X, PMID1822317, lire en ligne, consulté le )
(en) Suzanne Wood, Jennifer R. Sage, Tristan Shuman et Stephan G. Anagnostaras, « Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation », Pharmacological Reviews, vol. 66, no 1, , p. 193–221 (ISSN0031-6997, PMID24344115, PMCID3880463, DOI10.1124/pr.112.007054, lire en ligne, consulté le )
Kara Simone Bagot et Yifrah Kaminer, « Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review », Addiction (Abingdon, England), vol. 109, no 4, , p. 547–557 (ISSN0965-2140, PMID24749160, PMCID4471173, lire en ligne, consulté le )
(en) Nathan P, Lu K, Gray M et Oliver C, « The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent », J. Herb. Pharmacother, vol. 6, no 2, , p. 21-30 (PMID17182482)
(en) Kimura K, Ozeki M, Juneja L et Ohira H, « L-Theanine reduces psychological and physiological stress responses », Biol. Psychol., vol. 74, no 1, , p. 39-45 (PMID16930802)
(en) Lu K, Gray M, Oliver C, Liley D, Harrison B, Bartholomeusz C, Phan K et Nathan P, « The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans », Hum. Psychopharmacol, vol. 19, no 7, , p. 457-65 (PMID15378679)
J. Micheau, T. P. Durkin, C. Destrade et Y. Rolland, « Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation », Pharmacology, Biochemistry, and Behavior, vol. 23, no 2, , p. 195–198 (ISSN0091-3057, PMID4059305, DOI10.1016/0091-3057(85)90555-6, lire en ligne, consulté le )
Gillies D, Sinn JKh, Lad SS, Leach MJ et Ross MJ, « Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents », Cochrane Database Syst Rev, vol. 7, no 7, , p. CD007986 (PMID22786509, DOI10.1002/14651858.CD007986.pub2)
Tan ML, Ho JJ, Teh KH, « Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders », Cochrane Database Syst Rev, vol. 12, , p. CD009398 (PMID23235675, DOI10.1002/14651858.CD009398.pub2)
Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P, « Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis », J. Psychopharmacol. (Oxford), vol. 29, no 7, , p. 753–63 (PMID26040902, DOI10.1177/0269881115587958)
Forbes SC, Holroyd-Leduc JM, Poulin MJ, Hogan DB, « Effect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled Trials », Can Geriatr J, vol. 18, no 4, , p. 231–45 (PMID26740832, PMCID4696451, DOI10.5770/cgj.18.189)
(en) Guillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel, Alexandra Macgregor, Stéphanie Miot, Régis Lopez, Raphaëlle Richieri, Mocrane Abbar, Christophe Lancon et Dimitris Repantis, « Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review », Psychiatry Research, vol. 229, nos 1–2, , p. 12–20 (ISSN0165-1781, PMID26187342, DOI10.1016/j.psychres.2015.07.006)
Chrétien B, Hamel L, Bernier M, Daveluy A & Le Boisselier R (2017) Potentiel d’abus et de dépendance du lévétiracétam. Thérapie, 72(1), 168 (résumé).
Gouliaev, A. H. et Senning, A. (1994), Piracetam and other structurally related nootropics, Brain research reviews, 19(2), 180-222 (résumé).
Guillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel et Alexandra Macgregor, « Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review », Psychiatry Research, vol. 229, no 1, , p. 12–20 (ISSN0165-1781, DOI10.1016/j.psychres.2015.07.006, lire en ligne, consulté le )
telegraph.co.uk
(en) Sarah Knapton, « 'Smart drug' taken by one in four students really does boost performance », Telegraph.co.uk, (lire en ligne, consulté le ).